Abstract:Abstract Immunotherapies that modulate T cell function have been firmly established in cancer immunotherapy, whereas the potential for B cells in the antitumor immune response is not as well understood. B cell-activating factor (BAFF) is a cytokine belonging to the TNF ligand family that activates B cells and is linked to autoimmunity. Our preliminary research has identified BAFF as a target for enhancing antitumor immunity through enhancing presentation of tumor neoantigens and inducing tertiary lymphoid structures which can orchestrate tumor-specific T cell immune responses and correlate with improved clinical response. Since broad activation of B cell response could be detrimental and possibly induce autoimmune side effects, identification of specific B cell receptors that coordinate anti-tumor immunity is prudent. BAFF has three known receptors (BAFF-R, TACI and BCMA), and the effects of these specific BAFF ligand-receptor interactions on antitumor immunity are not known. Here we first generated BAFF-overexpressing cell lines using genomic editing [KPC-BAFF (pancreas), B16F10-BAFF (melanoma), and PancO2-BAFF (pancreas)] and examined their tumor growth in syngeneic immunocompetent host. Secondly, we investigated the effects of BAFF-overexpression on tumor response when individual receptors are knocked out using BAFF-R-KO, TACI-KO and BCMA-KO mice. Our results show significantly hindered tumor growth when the BAFF expressing stable cell lines are introduced to immunocompetent host, compared to parental cell lines. Tumor response experiments in receptor knockout mice is currently in progress. Successful identification of the BAFF receptor candidate that drives anti-tumor response is an exciting prospect for clinical translation. Development of agonists for the specific receptor may allow selective modulation of this particular B cell function in context of cancer therapy without perturbation of broad systemic humoral immunity. Citation Format: Khaled Aziz, Kabeer Munjal, Kathryn Howe, Mark Yarchoan. B-cell activating factor (BAFF) enhances antitumor immunity [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 3978.

Preparation and bioactivity characterization of recombinant human soluble mutant BAFF

Expression,purification and bioactivity identification of recombinant human BAFF fusion protein

Expression, purification, and characterization of recombinant human soluble BAFF secreted from the yeast Pichia pastoris

BAFF Promotes FLS Activation Through BAFFR-Mediated Non-canonical NF-κB Pathway and the Effects of CP-25.

Molecular structure, expression, and function analysis of BAFF gene in Chinese sucker, Myxocyprinus asiaticus

Development of a novel monoclonal antibody to B7-H4: characterization and biological activity

Current status of BAFF targeting immunotherapy in B-cell neoplasm

hsBAFF enhances activity of NK cells by regulation of CD4+ T lymphocyte function

Identify the Key Amino Acid of BAFF Binding with TACI.

B Cell-Activating Factor and Its Targeted Therapy in Autoimmune Diseases.

BAFF promotes follicular helper T cell development and germinal center formation through BR3 signal

Abstract 3978: B-cell activating factor (BAFF) enhances antitumor immunity

Expression of Rabbits BAFF in Escherichia Coli with Costimulatory Effect on B Cell Proliferation

Contributions of each of the BAFF receptors to the lymphocyte profiles in C57BL/6 mice

Antitumor efficacy of BAFF-R targeting CAR T cells manufactured under clinic-ready conditions

Enhanced Expression and Primary Purification of Soluble HBD3 Fusion Protein in Escherichia coli

Expressions of BAFF/BAFF Receptors and Their Correlation with Disease Activity in Chinese SLE Patients

Molecular Cloning, Expression and Functional Analysis of B-cell Activating Factor (BAFF) in Yellow Grouper, Epinephelus Awoara.

[Eukaryotic Expression and Determination of ZCH-7-2F9 Single Chain Antibody Against Human CD14].

Preparation of Recombinant Human IL-17A and IL-17F and Determination of Their Bioactivities

The Role BAFF and BAFF Receptors in Macrophage Induced Drug Resistance of Multiple Myeloma